HR 7142 (Alternatives to PAIN Act) requires Medicare Part D plans to cover non-opioid pain management drugs with no deductible and at the lowest copay level starting in 2025. It defines "qualifying non-opioid drugs" as FDA-approved medications that don’t act on opioid receptors (like certain NSAIDs or nerve pain treatments), excluding opioids and schedule I-III drugs. The bill prohibits Medicare plans from forcing patients to try opioids first (step therapy) or requiring prior approval for these non-opioid options. It directly affects Medicare beneficiaries needing pain management, especially those seeking alternatives to opioids for post-surgical or acute pain. The policy change aims to improve access to non-addictive pain treatments while preserving doctors' authority to prescribe medically appropriate care.
The EASE Act of 2024 requires the Centers for Medicare & Medicaid Services (CMS) to test a new model improving access to specialty health care for Medicare and Medicaid beneficiaries in rural or underserved areas. It mandates CMS to partner with selected provider networks - comprising at least 50 community health clinics, nonprofits with proven community health work, and commitment to research - to deliver specialty care via telehealth and remote technology, coordinated with patients’ primary care providers. This model directly affects Medicare Part A/B beneficiaries and Medicaid enrollees living in designated underserved regions. The bill establishes specific criteria for network selection and defines "eligible individuals" based on coverage type and geographic location.
This bill, the EMPSA Act (Eliminating the Marriage Penalty in SSI Act), changes Social Security Income (SSI) rules for married adults with intellectual or developmental disabilities. It directly affects married individuals aged 18+ who have these disabilities and meet income and resource limits. The key change removes the "marriage penalty" by ensuring their spouse’s income and resources no longer count against their SSI eligibility or benefit amount, allowing them to receive the full individual benefit rate. This update modifies specific sections of the Social Security Act to eliminate the previous disadvantage faced by married couples under these disability conditions.
This bill, HR 6860, protects patients with end-stage kidney disease (ESRD) who require dialysis by preventing health insurance plans from discriminating against them. It amends Medicare rules to prohibit plans from treating dialysis coverage differently than other medical services based on a patient’s ESRD diagnosis, need for dialysis, or any other factor. The bill clarifies that plans can still choose which dialysis providers to include in their networks but cannot deny or limit coverage for dialysis services solely because of the patient’s condition. It ensures Medicare remains the secondary payer for these services as intended, without forcing plans to cover specific providers.
The Preserving Seniors’ Access to Physicians Act of 2023 increases the Medicare payment adjustment rate for physicians from 1.25% to 4.62%, directly affecting doctors who treat Medicare patients (primarily seniors). It also reduces the funding for the Medicaid improvement fund from $5,796,117,810 to $3,973,117,810. These changes impact Medicare providers and Medicaid programs, with the Medicare adjustment aimed at supporting physicians adjusting to payment changes. The bill does not specify how the Medicaid funding reduction relates to its stated goal of preserving seniors' access to physicians.
This bill updates Medicare's physician fee schedule to better align with current healthcare costs and support providers. It extends a key deadline for geographic payment adjustments from 2024 to 2025, increases the rate for payment adjustments from 1.25% to 3%, and extends incentive payments for doctors in alternative payment models (APMs) through 2026. For 2026, it imposes payment reductions (34% for 4-6 years in APMs, 67% for 7+ years) but allows exceptions if providers increased their financial risk compared to 2025. The bill also raises Medicare's budget neutrality threshold to $53 million in 2025 and requires regular updates to cost data (like staff wages and equipment prices) every five years. These changes directly affect Medicare-participating physicians, especially those in APMs, by altering payment calculations and incentives.
This bill establishes new disability classifications (medical improvement expected, likely, possible, or not expected) to help determine when individuals might be able to return to work. It requires periodic disability reviews (every 5 years for "medical improvement possible," every 10 years for "medical improvement not expected") and limits benefits for those with expected or likely improvement to 23 or 59 months, respectively. The bill creates a "Return to Work" process allowing eligible individuals to gradually return to employment while receiving adjusted benefits, with benefits reduced by 50% of earnings above substantial gainful activity levels. Additionally, it increases funding for disability reviews and creates a tax credit for employers hiring disability beneficiaries.
HR 6407, the Medical Nutrition Therapy Act of 2023, expands Medicare coverage to include medical nutrition therapy for more chronic conditions beyond current limits. It directly affects Medicare beneficiaries with conditions like obesity, hypertension, dyslipidemia, eating disorders, and others not previously covered under Part B. The bill amends Medicare rules to allow coverage for prevention, management, or treatment of these conditions by a wider range of providers, including registered dietitians and clinical psychologists. This change would make medically necessary nutrition services available for conditions listed in the bill, such as diabetes, cardiovascular disease, and HIV, as determined by the Secretary.
HR 6344, the Simon Crosier Act, requires Medicare and Medicaid providers to establish written policies for do-not-resuscitate (DNR) orders involving unemancipated minors (under 18 without legal independence). It mandates that providers must inform at least one parent or legal guardian in person or by phone (with 72 hours of effort) before considering a DNR, allow parents/guardians to refuse consent, and prohibit overriding parental objections to life-sustaining treatment. The bill also requires providers to continue life-sustaining care for 15 days if a parent requests a transfer and explicitly prohibits using disability as the sole basis for DNR decisions. These requirements apply to all Medicare/Medicaid-covered facilities and directly affect minors, their parents, and healthcare providers.
HR 6280, the Smart Border Protection Act, provides $570 million in new funding for U.S. Customs and Border Protection (CBP) operations at ports of entry. It allocates $300 million for hiring personnel (including agents and specialists), $200 million for screening technology to detect threats like fentanyl in cargo, and $70 million for infrastructure improvements such as expanded vehicle lanes and building upgrades. All funds must be spent within one year of enactment and are in addition to existing appropriations. The bill directly supports CBP’s capacity to manage border security operations at designated ports.
The Maximum Pressure Act (HR 6114) is a legislative proposal that would maintain and expand U.S. sanctions against Iran. The bill would codify existing sanctions, require Iran to meet 12 specific conditions before sanctions could be lifted (including ending support for terrorism, releasing hostages, and ending nuclear enrichment), and expand sanctions on Iran's Revolutionary Guard Corps and missile programs. It also establishes new reporting requirements for the U.S. government to monitor Iran's activities and the impact of sanctions. The legislation would require congressional review before any sanctions could be lifted or modified, preventing the executive branch from unilaterally easing restrictions.
This bill, titled "Freezing HAMAS Act" (though it concerns Iran sanctions, not Hamas), reinstates U.S. sanctions on Iran that were previously waived or suspended under agreements with Iran. It specifically targets sanctions from the 2012 Iran Freedom and Counter-Proliferation Act and the 2012 National Defense Authorization Act, including a September 2023 waiver related to fund transfers. The bill prohibits the U.S. government from releasing funds or assets to Iran or granting further waivers related to these sanctions. It directly affects U.S. government actions regarding Iran financial transactions and enforcement of existing sanctions.
